EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Effective-Component Compatibility of Bufei Yishen Formula III Suppresses Mitochondrial Oxidative Damage in COPD: Via Pkm2/Nrf2 Pathway

Yang Liu iD, Lanxi Zhang, Jie Zhao, Ruilong Lu, Xuejie Shao, Kexin Xu, Jiansheng Li iD, Yange Tian

International Journal of Chronic Obstructive Pulmonary Disease · 2024

DOI: 10.2147/copd.s468825 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024. Verfasst von Yang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Constructed by Henan Province and Education Ministry of People's Rep…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Pulmonary Disease, Chronic Obstructive, Oxidative Stress, Signal Transduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China, Foundation of the Department of Science and Technology of HeNan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2Pulmonary Disease, Chronic ObstructiveOxidative StressSignal TransductionDisease Models, AnimalMitochondriaLungDrugs, Chinese HerbalAnimalsHumansA549 CellsMaleThyroid Hormone-Binding ProteinsPyruvate KinaseAntioxidantsRats, Sprague-DawleyCarrier ProteinsThyroid HormonesSmokeMembrane Proteins

Stichwörter der Autor:innen

ECC-BYF IIINrf2Pkm2chronic obstructive pulmonary diseaseoxidative stress

Substanzen

NF-E2-Related Factor 2Nfe2l2 protein, ratDrugs, Chinese HerbalNFE2L2 protein, humanPkm protein, ratThyroid Hormone-Binding ProteinsPyruvate KinaseAntioxidantsCarrier ProteinsThyroid Hormones

Autor:innen und Institutionen

  • Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Constructed by Henan Province and Education Ministry of People's Republic of China, Henan University of Chinese Medicine, Zhengzhou, Peopl…
  • School of Basic Medicine (Zhongjing School), Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
  • Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
  • First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, People's Republic of China.

ORCID-Profile: Yang Liu, Jiansheng Li

Förderung

  • National Natural Science Foundation of China
  • Foundation of the Department of Science and Technology of HeNan Province

Zitieren

APA

Liu, Y., Zhang, L., Zhao, J., Lu, R., Shao, X., Xu, K., Li, J., & Tian, Y. (2024). Effective-Component Compatibility of Bufei Yishen Formula III Suppresses Mitochondrial Oxidative Damage in COPD: Via Pkm2/Nrf2 Pathway. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s468825

Vancouver

Liu Y, Zhang L, Zhao J, Lu R, Shao X, Xu K, et al. Effective-Component Compatibility of Bufei Yishen Formula III Suppresses Mitochondrial Oxidative Damage in COPD: Via Pkm2/Nrf2 Pathway. International Journal of Chronic Obstructive Pulmonary Disease. 2024. doi:10.2147/copd.s468825

BibTeX
@article{Liu2024,
  author = {Liu, Yang and Zhang, Lanxi and Zhao, Jie and Lu, Ruilong and Shao, Xuejie and Xu, Kexin and Li, Jiansheng and Tian, Yange},
  title = {Effective-Component Compatibility of Bufei Yishen Formula III Suppresses Mitochondrial Oxidative Damage in COPD: Via Pkm2/Nrf2 Pathway},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2024},
  doi = {10.2147/copd.s468825}
}
Kostenlos starten →